The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases
Open accessAbstract
medium nor by the liver.The experiments with amyloglucosidase showed no difference in glycogen concentration in the liver nor in glucose release into the medium when compared with control per- fusions.Nevertheless there was penetration of liver tissue by circulating amyloglucosidase during perfusion corresponding to 0.03-0.4mg of enzyme/g wet wt. of liver (corrected for endogenous glucosidase activity).The concentration in liver was never greater than that in the medium.When amyloglucosidase was administered intra- venously to intact rats, a major proportion of the enzyme found in the liver was identified in a mito- chondrial-lysosomal fraction prepared by the pro- cedure of Lloyd (1969a), confirming the results of Lloyd (1969b).After perfusion with amyloglucosidase increased glucosidase activity was also as- sociated with a mitochondrial-lysosomal fraction.Although penetration of liver lysosomes by amylo- glucosidase apparently occurred during perfusion under the present conditions, the extent of this process was less than in vivo.This may be due to the absence of cofactors or to lysosomal damage in the isolated liver.Attempts to separate hepatocytes from Kupffer cells in an effort to identify the involvement of each in enzyme uptake in vivo have been made.We are grateful to the Wellcome Trust for financial support and to Professor Sir Ernst Chain for the use of departmental facilities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phospholipid spherules (liposomes) as a model for biological membranes
Sessa, G., & Weissmann, G. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43097-4 · Cited by 446
Enzyme entrapment in liposomes
Gregoriadis, G., Leathwood, P. D., & Ryman, B. E. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80109-6 · Cited by 331
Self-citationAN ELECTRON MICROSCOPIC AND BIOCHEMICAL STUDY OF TYPE II GLYCOGENOSIS.
Baudhuin, P., Hers, H. G., & Loeb, H. (1964) · PubMed · Cited by 247
Modification of Uricaemia and the Excretion of Uric Acid Nitrogen by an Enzyme of Fungal Origin
Kissel, P., Lamarche, M., & Royer, R. Q. (1968) · Nature · doi:10.1038/217072a0 · Cited by 39
Cited by
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
The Smart Drug Delivery System and Its Clinical Potential
Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066
Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,048
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
Nanoparticle-based drug delivery systems for cancer therapy
Dang, Y., & Guan, J. (2020) · Smart Materials in Medicine · doi:10.1016/j.smaim.2020.04.001 · Cited by 553
Metadata
- Authors
- Gregoriadis, G., & Ryman, B. E.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1971-10-01
- Volume
- 124
- Issue
- 5
- Pages
- 58P-58P
- ISSN
- 0306-3283 (ISSN-L)
- OpenAlex
- W148530083
- Cited by
- 286
- References
- 4
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. https://app.cochat.ai/papers/10.1042/bj1240058p
- The paper
- Gregoriadis, G., & Ryman, B. E. (1971). Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochemical Journal. https://doi.org/10.1042/bj1240058p
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.